Evaluation of Luminex xTAG Fungal Analyte-Specific Reagents for Rapid Identification of Clinically Relevant Fungi

Abstract

Invasive fungal infections (IFI) remain a serious threat to immunocompromised hosts. Current diagnostic methods, including fungal culture and antigen detection, are slow and often lack specificity. Rapid diagnostic tools with increased sensitivity and specificity could improve the care of patients with IFI. Recently, Luminex Molecular Diagnostics (Toronto, Canada) developed 23 analyte-specific reagents (ASRs) for the detection of the most common clinically relevant fungi. This study's objective was to evaluate the sensitivity and specificity of a subset of these ASRs for fungal isolates and clinical specimens. Previously characterized fungal and bacterial isolates ( n = 110), blood culture specimens ( n = 34), and respiratory specimens ( n = 44) were tested using either a Candida 7-plex panel ( Candida albicans , Candida glabrata , Candida tropicalis , Candida parapsilosis , Candida lusitaniae , Candida guilliermondii , and Candida krusei ) or a mold 11-plex panel ( Aspergillus fumigatus , Aspergillus flavus , Aspergillus niger , Aspergillus terreus , Scedosporium prolificans , Scedosporium apiospermum , Fusarium oxysporum / Fusarium solani , Rhizopus arrhizus , Rhizopus microsporus , Mucor indicus , and Cunninghamella bertholletiae ). The Candida 7-plex panel correctly identified all Candida isolates as confirmed by fungal culture and biochemical tests, for a sensitivity and specificity of 100%. The mold 11-plex panel correctly identified all mold isolates tested except for A. niger. Fungal isolates of Rhizopus and Mucor species were not detected, either, although they could represent species other than those targeted by the ASRs. Further evaluation will be necessary to confirm the sensitivities of some of the mold ASRs. Implementation of these ASRs will allow same-day detection of fungal DNA in clinical specimens.